Search hospitals > Alberta > CALGARY
Heritage Medical Research Clinic
Claim this profileCALGARY, Alberta T2N 4Z6
Conducts research for Crohn's Disease
Conducts research for Ulcerative Colitis
Conducts research for Colitis
Conducts research for Nonalcoholic Steatohepatitis
Conducts research for Alzheimer's Disease
52 reported clinical trials
0 medical researchers
Summary
Heritage Medical Research Clinic is a medical facility located in CALGARY, Alberta. This center is recognized for care of Crohn's Disease, Ulcerative Colitis, Colitis, Nonalcoholic Steatohepatitis, Alzheimer's Disease and other specialties. Heritage Medical Research Clinic is involved with conducting 52 clinical trials across 60 conditions. There are 0 research doctors associated with this hospital, such as .Top PIs
Clinical Trials running at Heritage Medical Research Clinic
Crohn's Disease
Amyotrophic Lateral Sclerosis
Motor Neuron Disease
Asthma
Fatty Liver
Nonalcoholic Steatohepatitis
Fatty Liver Disease
Heart Attack
Cardiovascular Risk
Colitis
Vedolizumab + Upadacitinib
for Crohn's Disease
The main aim of this study is to learn whether vedolizumab and upadacitinib given together (also called dual targeted therapy or DTT) reduces bowel inflammation and ulcers in the bowel compared to vedolizumab only (also called monotherapy) in adults with moderately or severely active Crohn's Disease (CD) after 12 weeks of treatment. Other aims are to learn how safe and effective DTT is compared to monotherapy for these participants. All participants will receive DTT (either vedolizumab and upadacitinib or vedolizumab and placebo) for 12 weeks. Participants responding to the treatment will then receive vedolizumab only (monotherapy) for an additional 40 weeks. During the study, participants will visit their study clinic 15 times.
Recruiting1 award Phase 32 criteria
Tulisokibart
for Crohn's Disease
The purpose of this protocol is to evaluate the efficacy and safety of tulisokibart in participants with moderately to severely active Crohn's disease. Study 1's primary hypotheses are that at least 1 tulisokibart dose level is superior to placebo in the proportion of participants achieving clinical remission per Crohn's Disease Activity Index score (\<150, US/FDA) or per stool frequency and abdominal pain score (EU/EMA) and in the proportion of participants achieving endoscopic response at Week 52 (US/FDA and EU/EMA), and that at least 1 tulisokibart dose level is superior to placebo in the proportion of participants achieving clinical remission per Crohn's Disease Activity Index score (\<150, US/FDA) or per stool frequency and abdominal pain score (EU/EMA) and in the proportion of participants achieving endoscopic response at Week 12 (US/FDA and EU/EMA). Study 2's primary hypothesis is that at least 1 tulisokibart dose level is superior to placebo in the proportion of participants achieving clinical remission per Crohn's Disease Activity Index score (\<150, US/FDA) or stool frequency and abdominal pain score (EU/EMA) and in the proportion of participants achieving endoscopic response at Week 12 (US/FDA and EU/EMA).
Recruiting1 award Phase 31 criteria
TAK-279
for Crohn's Disease
Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. The purpose of this study is to evaluate the efficacy and safety of TAK-279 versus placebo in participants with moderately to severely active Crohn's disease (CD). The main aim of this study is to learn if the 3 different doses of TAK-279 reduce bowel inflammation and ulcers in the bowel compared to the placebo after 12 weeks of treatment. Another aim is to compare any medical problems that participants have when they take TAK-279 or placebo and how well the participants tolerate medical problems. An endoscopy will be used to check the bowel for inflammation. The participants will be treated with TAK-279 for 52 weeks (1 year). During the study, participants will visit their study clinic 15 times.
Recruiting0 awards Phase 2
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Heritage Medical Research Clinic?
Heritage Medical Research Clinic is a medical facility located in CALGARY, Alberta. This center is recognized for care of Crohn's Disease, Ulcerative Colitis, Colitis, Nonalcoholic Steatohepatitis, Alzheimer's Disease and other specialties. Heritage Medical Research Clinic is involved with conducting 52 clinical trials across 60 conditions. There are 0 research doctors associated with this hospital, such as .
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.